Yatırımcı.AI

BISTTRY14:00Live

Türk İlaç ve Serum Sanayi A.Ş.

TRILC Ratio Analysis: P/E, P/B, EV/EBITDATürk İlaç ve Serum Sanayi A.Ş.

Watchlist MarketChemicals, Petroleum, Rubber and Plastics
0.70−0.01 (−1.41%)
Volume
TRY 1.9M
Day range
0.70 – 0.70
Previous close
0.71
Market cap
TRY 725.9M

Last updated: Source: Borsa Istanbul, 15-minute delayed

35 key ratios for Türk İlaç ve Serum Sanayi A.Ş. (TRILC) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E—
P/B0.51
EV/EBITDA3.89
Dividend yield—
Beta—
Earnings per share−0.7 TL
Book value per share1.4 TL
EBITDA778.9M TL
Net profit−577.3M TL
Operating profit432.8M TL
Operating profit before finance costs440.9M TL
Net working capital−1.3B TL
Gross margin32.92%
Operating margin11.92%
Net margin−15.90%
Return on assets−8.30%
Return on equity−41.13%
Current ratio0.80
Quick ratio0.63
Cash ratio—
Leverage ratio83.21
Debt to equity4.95
Debt to assets0.83
Fixed assets to equity2.25
Short-term debt share0.45
Interest coverage—
Receivables turnover0.33
Days sales outstanding1,106
Inventory turnover2.12
Days inventory outstanding172
Payables turnover1.42
Days payables outstanding257
Working capital turnover−2.74
Equity turnover2.53
Asset turnover0.43

Frequently Asked Questions

TRILC has a P/B ratio of 0.51 and an EV/EBITDA of 3.89.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.